Pages that link to "Q47621235"
Jump to navigation
Jump to search
The following pages link to Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age. (Q47621235):
Displaying 27 items.
- A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models (Q33820341) (← links)
- Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma (Q34350198) (← links)
- Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation (Q34402785) (← links)
- Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans (Q34666728) (← links)
- Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma (Q35118866) (← links)
- Inter-Institutional Comparison of Personalized Risk Assessments for Second Malignant Neoplasms for a 13-Year-Old Girl Receiving Proton versus Photon Craniospinal Irradiation. (Q35237529) (← links)
- The physics of proton therapy (Q35531022) (← links)
- Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy (Q36298040) (← links)
- Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk (Q36736612) (← links)
- Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient (Q36737527) (← links)
- Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator (Q36944265) (← links)
- Radiation-sensitive genetically susceptible pediatric sub-populations (Q37130076) (← links)
- Modeling the risk of secondary malignancies after radiotherapy (Q37590488) (← links)
- Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors (Q38093037) (← links)
- Defining the role of proton therapy in the optimal management of paediatric patients in Australia and New Zealand (Q38588047) (← links)
- Proton Radiotherapy for Pediatric Bladder/Prostate Rhabdomyosarcoma: Clinical Outcomes and Dosimetry Compared to Intensity-Modulated Radiation Therapy (Q39829271) (← links)
- Impact of Spot Size and Beam-Shaping Devices on the Treatment Plan Quality for Pencil Beam Scanning Proton Therapy (Q40258868) (← links)
- Monte Carlo simulation of secondary neutron dose for scanning proton therapy using FLUKA (Q42680182) (← links)
- Measurement of absorbed dose, quality factor, and dose equivalent in water phantom outside of the irradiation field in passive carbon‐ion and proton radiotherapies (Q43930815) (← links)
- Integral dose delivered to normal brain with conventional intensity-modulated radiotherapy (IMRT) and helical tomotherapy IMRT during partial brain radiotherapy for high-grade gliomas with and without selective sparing of the hippocampus, limbic cir (Q44259112) (← links)
- Empowering Intensity Modulated Proton Therapy Through Physics and Technology: An Overview (Q46126509) (← links)
- The effect of radiation quality on the risks of second malignancies (Q47714623) (← links)
- AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy (Q47947282) (← links)
- Lauriston S. Taylor lecture: radiation epidemiology--the golden age and future challenges (Q48540022) (← links)
- Measurement of stray radiation within a scanning proton therapy facility: EURADOS WG9 intercomparison exercise of active dosimetry systems. (Q53234220) (← links)
- Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy (Q83177251) (← links)
- Enhancement of Radiation Effectiveness in Proton Therapy: Comparison Between Fusion and Fission Methods and Further Approaches (Q90664641) (← links)